← Leaderboards
Bryan Hoang
Arrevus, Inc.
$672,647
Attributed
$672,647
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$672,647 · 1
By mechanism
R42$672,647 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Adjuvant Therapy”
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Jean Kwun · Duke University$5,686,708
- Patrick R Secor · University Of Montana$4,394,600
- Holly Rockweiler · Madorra, Inc.$4,300,000
- Kenneth B. Bader · University Of Chicago$4,178,329
- Alexandra Margaret Lynn Binder · University Of California Los Angeles$4,065,524
Research focus
Adjuvant TherapyAntibiotic ResistanceAntibioticsAntibiotic TherapyAntimicrobialAntimicrobial PeptideBacteremiaBacteriaBacterial Antibiotic ResistanceBacterial ProteinsBaseCenters For Disease Control And Prevention (U.S.)Clinical CareColistinCombatDefense MechanismsDoseDrug KineticsDrug ResistanceEconomic ImpactEfficacy StudyEvaluationExhaustAcinetobacter Baumannii